已收盘 05-08 16:00:00 美东时间
+1.700
+2.18%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Minerals Technology业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q1营收5.47亿美元,同比增长11%,环比增长5% - 消费者及特种材料业务营收2.97亿美元,同比增长11% - 工程解决方案业务营收2.50亿美元,同比增长12% **盈利能力:** - 营业收入6,800万美元(剔除特殊项目),同比增长7%,环比增长100万美元 - 每股收益1.38美元(剔除特殊项目),同比增长21% - 消费者及特种材料业务营业收入3,300万美元,同比增长8% - 工程解决方案业务营业收入3,90
05-02 12:19
Minerals Technologies shares are trading higher after the company reported bett...
05-02 01:53
Minerals Technologies (NYSE:MTX) held its first-quarter earnings conference cal...
05-02 00:00
Minerals Technologies (NYSE:MTX) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.25 by 10.4 percent. This is a 21.05 percent increase over earnings of $1.14 per share from
05-01 05:01
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
Minerals Technologies Inc. (NYSE: MTX) announced it will release its first quarter 2026 results on April 30, 2026, after market close. A conference call discussing the results will be held on May 1 at 11 a.m. ET. Investors can access the webcast and materials via MTI’s Investor Relations page or pre-register using the provided link. The dial-in numbers are +1 877-270-2148 (US) and +1 412-902-6510 (international). A replay will be available from 2...
04-02 13:40
MTX posts FY 2025 net loss attributable to shareholders of USD 18.4 million Minerals Technologies (MTX) reported FY 2025 net sales of USD 2.07 billion (-2%), with income from operations of USD 47.4 million versus an operating margin of 2.3%. Net income (loss) attributable to shareholders was a loss
02-21 04:04